MYCN and neuroblastoma: Thus, our pharmaceutical inhibition assays reflect our genetic interference data, showing that NB cell-lines are sensitive to both UNC0638 and UNC0642, with MYCN over-expressing cells being significantly more sensitive than non-MNA lines.